Skip to main content

Animations

MJFF Publications

3641 - 3650 of 9148 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2018
  • 2021
  • 2023
  • 2020
  • 2020
  • 2021
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization Websites
    Journal Name: Frontiers in Communication
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcomm.2021.716683
    Citation Count: 8
  • Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
    2021
    Summary Details
    RESTRICTED
    Title: Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
    Journal Name: Current Drug Research Reviews
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2174/2589977513666210211163711
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Леводопа/карбідопа пролонгованого вивільнення в лікуванні хвороби Паркінсона
    Journal Name: INTERNATIONAL NEUROLOGICAL JOURNAL
    Publisher: Publishing House Zaslavsky
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.22141/2224-0713.3.97.2018.133682
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders
    Journal Name: Current Chinese Chemistry
    Publisher: Bentham Science Publishers Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2174/2666001601666211126091737
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Unconventional initiation of PINK1/Parkin mitophagy by Optineurin
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.04.021
    Citation Count: 113
  • Summary Details
    OPEN
    Title: REM sleep behavior disorder in early Parkinson’s disease predicts the rapid dopaminergic denervation
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.032
    Citation Count: 20
  • Apolipoprotein E ε4 genotype and risk of freezing of gait in Parkinson's disease
    2020
    Summary Details
    RESTRICTED
    Title: Apolipoprotein E ε4 genotype and risk of freezing of gait in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.033
    Citation Count: 21
  • Summary Details
    OPEN
    Title: North American survey on impact of the COVID-19 pandemic shutdown on DBS care
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011
    Citation Count: 9
  • Summary Details
    OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Developing therapies for Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.